☆ 4.6 Letter

Long-Term Administration of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reduces Arterial FDG Uptake

JACC-CARDIOVASCULAR IMAGING (2019)

Get Full Text
Add to Collection

Journal

JACC-CARDIOVASCULAR IMAGING
Volume 12, Issue 12, Pages 2573-2574

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2019.09.024

Keywords

-

Categories

Cardiac & Cardiovascular Systems Radiology, Nuclear Medicine & Medical Imaging

Funding

  1. project The Greek research infrastructure for personalized medicine (pMED-GR) - Operational Programme Competitiveness, Entrepreneurship and Innovation (NSRF 2014-2020) [MIS 5002802]
  2. European Union (European Regional Development Fund)
  3. Amgen
  4. Elpen
  5. MSD
  6. Mylan
  7. Sanofi
  8. Servier
  9. Angelini
  10. Lilly
  11. Vianex
  12. Bayer
  13. Menarini

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.